Back to search

Article

Development of a novel mechanism-based glycolipid adjuvant for vaccination

2018-05-30

Abstract excerpt

The inability to elicit strong and durable cellular responses is a major obstacle in the development of successful vaccines, in particular those against malaria. In this regard, the generation of novel adjuvants that will potently boost cell-mediated immunity induced by candidate vaccines is helpful. We and others have found a glycolipid, called α-galactosylceramide (α-GalCer), which could be presented on CD1d exp...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
7b7cdd17-065f-5293-811b-e244faebc2a4
DOI
10.12688/f1000research.13794.1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Development of a novel mechanism-based glycolipid adjuvant for vaccinationDOI 10.12688/f1000research.13794.1
Select a neighboring publication to make it the new centre.